BENEFIT Act of 2021

Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.3916/S.1840) Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472) Palliative Care and Hospice Education Training Act (PCHETA)

Client expense: Not reported · Firm income: $40,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

Health disparities Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access in during emergencies Polices related to PBM and drug cost transparency Policies related to COVID-19 vaccination distribution Policies impacting immunocompromised people, including COVID-19 vaccination and monoclonal antibody distribution Policies related to reducing the cost of cancer treatment for patients Policies related to decline in breast cancer screenings during the COVID-19 pandemic Policies related to genetic counseling and screening Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 Policies related to the implementation of the Breast Density and Mammography Reporting Act of 2017 and the 2023 Final Rule Amending Part 900 of the Mammography Quality Standards Act Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021, requiring the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs (S.373/ H.R.4472)

Client expense: Not reported · Firm income: $40,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

Transparency. Copay Accumulators/Maximizers. Benefit Design. Quality-Adjusted Life Years. Home Health Services. National Coverage Determination H.R.5376 - Inflation Reduction Act of 2022. H.R.2163/S464 - Safe Step Act. H.R.3173/S.3018 - Improving Seniors Timely Access to Care Act. H.R.5801 - HELP Copays Act. H.R.7667 - Food and Drug Amendments of 2022. H.R.4472/S.373 - BENEFIT Act of 2021. H.R.7634 - Protecting Health Care for All Patients Act. H.R.8581/S.4605 - Preserving Access to Home Health Act. S.4348 - FDASLA Act of 2022. H.R.5067/S.2652 - Preserving Access to Home Infusion Act. H.R.8800 - Medicare Providers Act.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H. RES. 1330 H.R. 6216/S. 3389, the Sickle Cell Disease Comprehensive Care Act H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 S. 1644/H.R. 3761, the Promising Pathway Act S. 373/H.R. 4472, the BENEFIT Act of 2021 H.R.2623, Camerons Law

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA); VALID Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid home and community based services (HCBS); orphan & rare disease issues, including Orphan Drug Tax Credit; coverage restrictions; Better Care Better Jobs Act (H.R. 4131/S. 2210); 21st Century Cures Act (P.L. 114-255); Safe Step Act (H.R. 2163/ S. 464); Cures 2.0 (H.R. 6000); BENEFIT Act (H.R. 4472; S. 373); Money Follows the Person; Medicaid Spousal Impoverishment; Access to Accessible Medical Equipment (ACA Sec. 1557); NIH research

Client expense: $75,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Lobbied for changes to Veterans Benefits Administration's (VBA) employee performance standards. Lobbied for increased oversight and changes to performance standards for Legal Administrative Assistants in the VBA National Call Centers. Lobbied for comprehensive changes to internal VBA processes for claims, including changes to the VBA National Work Queue. Lobbied to require the VA to include VA employee input when making changes to the claims process, employee performance standards, and training for claims processors. Lobbied on the processing of complex claims within the Veterans Benefits Administration, including how it relates to Military Sexual Trauma, Traumatic Brain Injury Lobbied for the specialization of claims processing for highly complex cases. Lobbied for reimbursement for bar membership dues for attorneys working at the Board of Veterans' Appeals. Lobbied for changes to the Strengthening Oversight for Veterans Act that improperly authorizes an agency IG to issue testimonial subpoenas to former employees and others without the safeguards provided to current employees. Lobbied for changes to prior to the introduction of H.R. 8510, the Strengthening Whistleblower Protections at the Department of Veterans Affairs Act to remove provisions that would improperly expand the Office of Special Counsel's authority at the expense of the neutral Merit Systems Protection Board and afford overly broad protections to SES members. C&P Exams: Lobbied against contracting out of Compensation and Pension (C&P) Exams and bringing those exams back into the VA. Lobbied to keep all specialty C&P Exams including but not limited to Traumatic Brain Injury (TBI), Post Traumatic Stress Disorder (PTSD), Military Sexual Trauma (MST), veterans who served as Prisoners of War (POWs), veterans who suffered catastrophic injuries, and veterans who are currently eligible (or will likely soon be eligible) to pursue toxic exposure claims. Lobbied for the VA to utilize more internal C&P Providers by hiring more staff and returning staff to C&P positions who had previously been reassigned. Lobbied to keep Integrated Disability Evaluation System (IDES) Exams within the VA. Lobbied for the continued oversight of contract C&P Exams. Lobbied to make sure the VA is in compliance with Section 2002 of the Johnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020. Collective Bargaining Rights: Lobbied for H.R. 6682, the "Protecting VA Employees Act" to repeal parts of the VA Accountability Act. Lobbied in support of H.R. 1948/S. 771, the "VA Employee Fairness Act." Lobbied in support of the implementation of the withdrawal of President Trump's May 2018 Executive Orders 13836, 13837, and 13839. Lobbied in support of the implementation of President Biden's January 2021 Executive Order 14003: "Protecting the Federal Workforce in a timely fashion." Lobbied for oversight into the Biden Administration's implementation of Executive Order 4003. VA Infrastructure: VA HR Modernization: Lobbied to address problems created by VA reorganization of its human resources processes including centralization and implementation of new information technology systems, and practices and policies related to filling and posting unfilled positions. VA Compensation: Lobbied in support of H.R. 6398/S. 3518, the "FAIR Act" to raise pay for federal employees at the VA. Lobbied in support of H.R. 304/S. 4221 "Equal COLA Act" to protect VA employees in FERS. Lobbied in support of H.R. 3693, the "VA CPE Modernization Act." Lobbied for the need for increased compensation for mid-grade Title 38 employees in positions covered by the "VA Nurse and Physician Assistant RAISE Act." Lobbied for the increase use of market pay surveys for Title 38 employees, and for Congress to perform oversight over the VA to ensure these surveys are being completed regularly and accurately. VA Asset Infrastructure Review (AIR) Act: Lobbied to block the confirmation of the AIR Commission members and prevent implementation of recommendations to close facilities and reduce patient capacity. Lobbied to repeal the AIR Act and in support of S. 4297, the "Elimination of the VA Asset and Infrastructure Review (AIR) Commission Act of 2022", a draft House companion bill, and a proposed amendment to H.R. 7900, the "National Defense Authorization Act", substantially similar to S. 4297. Lobbied to amend H.R. 8238, the "Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill, 2023" and parallel draft Senate legislation to prohibit closure of VA health care facilities based on certain VA recommendations to the AIR Commission. Lobbied for the VA to hire staff to fill its tens of thousands of vacancies. Lobbied for the inclusion of Questions for the Record to the VA Secretary on AIR Commission market assessment data transparency. Lobbied in support introduction of legislation, existing legislation, and amendments to repeal the AIR Commission. Testimony, Statements for the Record, and Letters: Letter to the Senate Veterans Affairs Committee for a Legislative Hearing on July 13, 2022 Letter to the House Veterans Affairs Committee for a Markup on July 19, 2022. Provided questions to members of the Senate Veterans Affairs Committee for a hearing on July 27, 2022. Letter to the House Veterans Affairs Committee for a Markup on September 21, 2022. Provided questions to members of the Senate Veterans Affairs Committee for a hearing on September 21, 2022. Specific Legislation: Lobbied in support of H.R. 1948/S. 771, the "VA Employee Fairness Act." Lobbied in support of H.R. 962/S. 1888, the "Law Enforcement Officer Equity Act" and the importance of this bill to the VA Police Force. Lobbied in support of H.R. 3693, the "VA CPE Modernization Act," and its amended version. Lobbied in support of H.R. 6398/S. 3518, the "FAIR Act" to raise pay for federal employees at the VA. Lobbied in support of S. 4156, the VA Workforce Improvement, Support, and Expansion (WISE) Act of 2022. Also lobbied for specific changes to the bill related to VA Police Pensions, Continuing Professional Education Benefits, Performance Pay, Collective Bargaining Rights for Title 38 Employees, and changes for protections for former federal employees in relation to IG investigations. H.R. 304/S. 4221, the "Equal COLA Act" to protect VA employees in FERS. Lobbied in support of H.R. 6682, the "Protecting VA Employees Act" to amend parts of the VA Accountability and Whistleblower Protection Act. Lobbied in support of H.R. 4673, the "Ensuring Veterans' Smooth Transition Act" or "EVEST Act Lobbied in support of S. 3372, To amend title 38, United States Code, to strengthen benefits for children of Vietnam veterans born with spina bifida, and for other purposes. Lobbied in support of S. 3548, the Veterans Hearing Benefits Act of 2022. Lobbied in support of S. 4141, A bill to amend title 38, United States Code, to establish in the Department of Veterans Affairs as Advisory Committee on United States Outlying Areas and Freely Associated States, and for other purposes. Lobbied in support of S. 4308, the Veterans Marriage Recognition Act. Lobbied in support of H.R. 8888, the Food Security for All Veterans Act. Lobbied in opposition to H.R. 2800, the Working to Integrate Networks Guaranteeing Member Access Now Act or the WINGMAN Act Lobbied for changes to and supported H.R. 8510, the Strengthening Whistleblower Protections at the Department of Veterans Affairs as amended. Lobbied in support of H.R. 6823, the Elizabeth Dole Home and Community Based Service for Veterans and Caregivers Act of 2022 as amended. Lobbied in support of H.R. 8260, the Faster Payments to Veterans Survivors Act of 2022. Lobbied in support of H.R. 5776, the Serving Our LGBTQ Veterans Act Lobbied for in support of and for technical changes to H.R. 8003, the Restore Veterans Dignity Act of 2022. Lobbied in support of the amended version of H.R. 8313, the House Every Veterans Act. Lobbied in opposition to the amended version of H.R. 291 the COST SAVINGS Enhancement Act Made comments on H.R. 6647, a bill to make certain improvements relating to the eligibility of veterans to receive reimbursement for emergency treatment furnished through the Veterans Community Care program, and for other purposes. Lobbied in opposition to H.R. 7188, the Modernizing Department of Veterans Affairs Disability Benefit Questionnaires Act. Lobbied in support of S. 3373, the "Honoring the PACT Act," Lobbied against SA 5185 (Blackburn) to S. 3373 Lobbied against SA 5186 (Toomey) to S. 373

Client expense: Not reported · Firm income: $9,856

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

Transparency. Copay Accumulators/Maximizers. Benefit Design. Quality-Adjusted Life Years. Home Health Services. H.R.5376 - Inflation Reduction Act of 2022. H.R.2163 - Safe Step Act. H.R.3173 - Improving Seniors Timely Access to Care Act. H.R.5801 - HELP Copays Act. H.R.7667 - Food and Drug Amendments of 2022. H.R.4472 - BENEFIT Act of 2021. H.R.7634 - Protecting Health Care for All Patients Act. H.R.8581 - Preserving Access to Home Health Act. S.464 - Safe Step Act. S.3018 - Improving Seniors Timely Access to Care Act. S4348 - FDASLA Act of 2022. S.373 - BENEFIT Act of 2021. S.4605 - Preserving Access to Home Health Act.

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied for changes to Veterans Benefits Administration's (VBA) employee performance standards. Lobbied for increased oversight and changes to performance standards for Legal Administrative Assistants in the VBA National Call Centers. Lobbied for comprehensive changes to internal VBA processes for claims, including changes to the VBA National Work Queue. Lobbied to require the VA to include VA employee input when making changes to the claims process, employee performance standards, and training for claims processors. Lobbied on the processing of complex claims within the Veterans Benefits Administration, including how it relates to Military Sexual Trauma, Traumatic Brain Injury Lobbied for the specialization of claims processing for highly complex cases. Lobbied for reimbursement for Bar Membership dues for attorneys working at the Board of Veterans' Appeals. Lobbied for changes to the Strengthening Oversight for Veterans Act that improperly authorizes an agency IG to issue testimonial subpoenas to former employees and others without the safeguards provided to current employees. Lobbied for changes prior to the introduction of H.R. 8510, the Strengthening Whistleblower Protections at the Department of Veterans Affairs Act to remove provisions that would improperly expand the Office of Special Counsel's authority at the expense of the neutral Merit Systems Protection Board and afford overly broad protections to SES members. C&P Exams: Lobbied against contracting out of Compensation and Pension (C&P) Exams and bringing those exams back into the VA. Lobbied to keep all specialty C&P Exams including but not limited to Traumatic Brain Injury (TBI), Post Traumatic Stress Disorder (PTSD), Military Sexual Trauma (MST), veterans who served as Prisoners of War (POWs), veterans who suffered catastrophic injuries, and veterans who are currently eligible (or will likely soon be eligible) to pursue toxic exposure claims. Lobbied for the VA to utilize more internal C&P Providers by hiring more staff and returning staff to C&P positions who had previously been reassigned. Lobbied to keep Integrated Disability Evaluation System (IDES) Exams within the VA. Lobbied for the continued oversight of contract C&P Exams. Lobbied to make sure the VA is in compliance with Section 2002 of the Johnny Isakson and David P. Roe, M.D. Veterans Health Care and Benefits Improvement Act of 2020. Collective Bargaining Rights: Lobbied for H.R. 6682, the "Protecting VA Employees Act" to repeal parts of the VA Accountability Act. Lobbied in support of H.R. 1948/S. 771, the "VA Employee Fairness Act." Lobbied in support of the implementation of the withdrawal of President Trump's May 2018 Executive Orders 13836, 13837, and 13839. Lobbied in support of the implementation of President Biden's January 2021 Executive Order 14003: "Protecting the Federal Workforce in a timely fashion." Lobbied for oversight of the Biden Administration's implementation of Executive Order 4003. VA HR Modernization: Lobbied to address problems created by VA reorganization of its human resources processes including centralization and implementation of new information technology systems, and practices and policies related to filling and posting unfilled positions. VA Compensation: Lobbied in support of H.R. 6398/S. 3518, the "FAIR Act" to raise pay for federal employees at the VA. Lobbied in support of H.R. 304/S. 4221 "Equal COLA Act" to protect VA employees in FERS. Lobbied in support of H.R. 3693, the "VA CPE Modernization Act." Lobbied for increased compensation for mid-grade Title 38 employees in positions covered by the "VA Nurse and Physician Assistant RAISE Act." Lobbied for the increased use of Market Pay Surveys for Title 38 employees, and for Congress to perform oversight over the VA to ensure these surveys are being completed regularly and accurately. VA Asset Infrastructure Review (AIR) Act Lobbied to block the confirmation of the AIR Commission members and prevent implementation of recommendations to close facilities and reduce patient capacity. Lobbied to repeal the AIR Act and in support of S. 4297, the "Elimination of the VA Asset and Infrastructure Review (AIR) Commission Act of 2022", a draft House companion bill, and a proposed amendment to H.R. 7900, the "National Defense Authorization Act", substantially similar to S. 4297. Lobbied to amend H.R. 8238, the "Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill, 2023" and parallel draft Senate legislation to prohibit closure of VA health care facilities based on certain VA recommendations to the AIR Commission. Lobbied for the VA to hire staff to fill its tens of thousands of vacancies. Lobbied for the inclusion of Questions for the Record to the VA Secretary on AIR Commission market assessment data transparency. Lobbied in support new legislation, existing legislation, and amendments to repeal the AIR Commission. Testimony, Statements for the Record, and Letters: (Add Apostrophe after Veterans for both committees) Letter to the Senate Veterans Affairs Committee for a Legislative Hearing on July 13, 2022. Letter to the House Veterans Affairs Committee for a Markup on July 19, 2022. Provided questions to members of the Senate Veterans Affairs Committee for a hearing on July 27, 2022. Letter to the House Veterans Affairs Committee for a Markup on September 21, 2022. Provided questions to members of the Senate Veterans Affairs Committee for a hearing on September 21, 2022. Specific Legislation: Lobbied in support of H.R. 1948/S. 771, the "VA Employee Fairness Act." Lobbied in support of H.R. 962/S. 1888, the "Law Enforcement Officer Equity Act" and the importance of this bill to the VA Police Force. Lobbied in support of H.R. 3693, the "VA CPE Modernization Act," and its amended version. Lobbied in support of H.R. 6398/S. 3518, the "FAIR Act" to raise pay for federal employees at the VA. Lobbied in support of S. 4156, the VA Workforce Improvement, Support, and Expansion (WISE) Act of 2022. Also lobbied for specific changes to the bill related to VA Police Pensions, Continuing Professional Education Benefits, Performance Pay, Collective Bargaining Rights for Title 38 Employees, and changes for protections for former federal employees in relation to IG investigations. Lobbied in support of H.R. 304/S. 4221, the "Equal COLA Act" to protect VA employees in FERS. Lobbied in support of H.R. 6682, the "Protecting VA Employees Act" to amend parts of the VA Accountability and Whistleblower Protection Act. Lobbied in support of H.R. 4673, the "Ensuring Veterans' Smooth Transition Act" or "EVEST Act Lobbied in support of S. 3372, To amend title 38, United States Code, to strengthen benefits for children of Vietnam veterans born with spina bifida, and for other purposes. Lobbied in support of S. 3548, the Veterans Hearing Benefits Act of 2022. Lobbied in support of S. 4141, A bill to amend title 38, United States Code, to establish in the Department of Veterans Affairs as Advisory Committee on United States Outlying Areas and Freely Associated States, and for other purposes. Lobbied in support of S. 4308, the Veterans Marriage Recognition Act. Lobbied in support of H.R. 8888, the Food Security for All Veterans Act. Lobbied in opposition to H.R. 2800, the Working to Integrate Networks Guaranteeing Member Access Now Act or the WINGMAN Act. Lobbied for changes to and supported H.R. 8510, the Strengthening Whistleblower Protections at the Department of Veterans Affairs as amended. Lobbied in support of H.R. 6823, the Elizabeth Dole Home and Community Based Service for Veterans and Caregivers Act of 2022 as amended. Lobbied in support of H.R. 8260, the Faster Payments to Veterans Survivors Act of 2022. Lobbied in support of H.R. 5776, the Serving Our LGBTQ Veterans Act. Lobbied for in support of and for technical changes to H.R. 8003, the Restore Veterans Dignity Act of 2022. Lobbied in support of the amended version of H.R. 8313, the House Every Veterans Act. Lobbied in opposition to the amended version of H.R. 291 the COST SAVINGS Enhancement Act. Made comments on H.R. 6647, a bill to make certain improvements relating to the eligibility of veterans to receive reimbursement for emergency treatment furnished through the Veterans Community Care program, and for other purposes. Lobbied in opposition to H.R. 7188, the Modernizing Department of Veterans Affairs Disability Benefit Questionnaires Act. Lobbied in support of S. 3373, the "Honoring the PACT Act." Lobbied against SA 5185 (Blackburn) to S. 3373. Lobbied against SA 5186 (Toomey) to S. 373.

Client expense: $450,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA); VALID Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid home and community based services (HCBS); orphan & rare disease issues, including Orphan Drug Tax Credit; coverage restrictions; Better Care Better Jobs Act (H.R. 4131/S. 2210); 21st Century Cures Act (P.L. 114-255); Safe Step Act (H.R. 2163/ S. 464); Cures 2.0 (H.R. 6000); BENEFIT Act (H.R. 4472; S. 373); NIH research

Client expense: $75,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 4472: BETTER EMPOWERMENT NOW TO ENHANCE FRAMEWORK AND IMPROVE TREATMENTS (BENEFIT) ACT OF 2021; ALL PROVISIONS OF THE BILL HR 6000: CURES 2.0 ACT: PROVISIONS RELATED TO SECTIONS 203, 204, 303-309, 402, 403, 407 HR 6584: DIVERSE AND EQUITABLE PARTICIPATION IN CLINICAL TRIALS (DEPICT) ACT; ALL PROVISIONS OF THE BILL HR 6888: HELPING EXPERTS ACCELERATE RARE TREATMENTS ACT OF 2022; ALL PROVISIONS OF THE BILL HR 6963: ACCELERATED APPROVAL INTEGRITY ACT OF 2022; ALL PROVISIONS OF THE BILL HR 6996: ACCELERATING ACCESS FOR PATIENTS ACT OF 2022; ALL PROVISIONS OF THE BILL HR 7667: FOOD AND DRUG AMENDMENTS OF 2022; PROVISIONS RELATED TO TITLE V, SECTIONS 703 AND 804 S 373: BETTER EMPOWERMENT NOW TO ENHANCE FRAMEWORK AND IMPROVE TREATMENTS (BENEFIT) ACT OF 2021; ALL PROVISIONS OF THE BILL S 4071: HELPING EXPERTS ACCELERATE RARE TREATMENTS ACT OF 2022; ALL PROVISIONS OF THE BILL S 4348: FOOD AND DRUG ADMINISTRATION SAFETY AND LANDMARK ADVANCEMENTS ACT OF 2022 (FDASLA ACT); PROVISIONS RELATED TO SECTION 506 GENERAL DISCUSSIONS REGARDING ISSUES AFFECTING GENETIC BONE DISORDERS GENERAL DISCUSSIONS REGARDING HEMOPHILIA GENE THERAPY

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 373 H.R. 4472 H.R. 7667 S. 4348 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act Orphan Drug Tax Credit

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act H.R. 1184, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 6000, the Cures 2.0 Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA); VALID Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid home and community based services (HCBS); orphan & rare disease issues, including Orphan Drug Tax Credit; coverage restrictions; Better Care Better Jobs Act (H.R. 4131/S. 2210); 21st Century Cures Act (P.L. 114-255); Safe Step Act (H.R. 2163/ S. 464); Cures 2.0 (H.R. 6000); BENEFIT Act (H.R. 4472; S. 373); NIH research

Client expense: $45,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 373 and HR 4472 the BENEFIT Act of 2021; The Prescription Drug User Fee Agreement of 2022; ensure patient access to rare disease treatments

Client expense: Not reported · Firm income: Not reported

HR 4472: BETTER EMPOWERMENT NOW TO ENHANCE FRAMEWORK AND IMPROVE TREATMENTS (BENEFIT) ACT OF 2021; ALL PROVISIONS OF THE BILL HR 6000: CURES 2.0 ACT: PROVISIONS RELATED TO SECTIONS 203, 204, 303-309, 402, 403, 407 HR 6584: DIVERSE AND EQUITABLE PARTICIPATION IN CLINICAL TRIALS (DEPICT) ACT; ALL PROVISIONS OF THE BILL HR 6888: HELPING EXPERTS ACCELERATE RARE TREATMENTS (HEART) ACT OF 2022; ALL PROVISIONS OF THE BILL HR 6963: ACCELERATED APPROVAL INTEGRITY ACT OF 2022; ALL PROVISIONS OF THE BILL HR 6996: ACCELERATING ACCESS FOR PATIENTS ACT OF 2022: ALL PROVISIONS OF THE BILL S 373: BETTER EMPOWERMENT NOW TO ENHANCE FRAMEWORK AND IMPROVE TREATMENTS (BENEFIT) ACT OF 2021; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING VALUE-BASED PAYMENT ARRANGEMENTS (VBA)

Client expense: $560,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 5989 - Precision Medicine Answers for Kids Today Act (PMAKTA).

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid home and community based services (HCBS); orphan & rare disease issues, including Orphan Drug Tax Credit; coverage restrictions; Better Care Better Jobs Act (H.R. 4131/S. 2210); 21st Century Cures Act (P.L. 114-255); Safe Step Act (H.R. 2163/ S. 464); Cures 2.0 (H.R. 6000); Build Back Better (H.R. 5376); BENEFIT Act (H.R. 4472; S. 373)

Client expense: $35,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 4393 - Advancing Precision Medicine Act; H.R. 3783, S. 2013 - Medical Nutrition Equity Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1730, S. 670 - STAT Act; H.R. 482, S. 350 - Newborn Screening Save Lives Reauthorization Act; Cures 2.0; PDUFA; ARPA-H; Telehealth; Covid-relief; Appropriations; S. 373, H.R. 4472 - Better Empowerment Now to Enhance Framework to Improve Treatments (BENEFIT) Act; H.R. 2144, S. 1450 - Access to Genetic Counselor Services Act; H.R. 4393 - Advancing Precision Medicine Act; H.R. 3783, S. 2013 - Medical Nutrition Equity Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS OF THE BILL HR 1184: HELPING EXPERTS ACCELERATE RARE TREATMENTS (HEART) ACT OF 2021; ALL PROVISIONS OF THE BILL S 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS OF THE BILL S 373: BENEFIT ACT OF 2021; PROVISIONS RELATED TO RARE DISEASES S 2164: LOWER COSTS, MORE CURES ACT OF 2021; PROVISIONS RELATED TO VALUE BASED ARRANGEMENTS GENERAL DISCUSSIONS RELATED TO THE 21ST CENTURY CURES ACT 2.0 GENERAL DISCUSSIONS RELATED TO THE ORPHAN DRUG ACT

Client expense: $190,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE